GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $703,000 | 0.0% | 16,146 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $703,000 | -1.5% | 16,146 | -0.3% | 0.01% | -12.5% |
| Q4 2021 | $714,000 | +11.9% | 16,200 | -3.0% | 0.02% | +6.7% |
| Q3 2021 | $638,000 | -4.1% | 16,700 | 0.0% | 0.02% | +7.1% |
| Q2 2021 | $665,000 | -20.7% | 16,700 | -28.9% | 0.01% | -26.3% |
| Q1 2021 | $839,000 | -2.6% | 23,500 | +0.4% | 0.02% | -34.5% |
| Q4 2020 | $861,000 | -1.4% | 23,400 | +0.9% | 0.03% | -17.1% |
| Q3 2020 | $873,000 | -7.7% | 23,200 | 0.0% | 0.04% | +2.9% |
| Q2 2020 | $946,000 | +9.0% | 23,200 | +1.3% | 0.03% | -10.5% |
| Q1 2020 | $868,000 | -21.7% | 22,896 | -3.0% | 0.04% | +22.6% |
| Q4 2019 | $1,109,000 | +10.1% | 23,596 | 0.0% | 0.03% | +3.3% |
| Q3 2019 | $1,007,000 | +2.3% | 23,596 | -4.1% | 0.03% | +11.1% |
| Q2 2019 | $984,000 | -3.6% | 24,596 | +0.7% | 0.03% | -3.6% |
| Q1 2019 | $1,021,000 | – | 24,423 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |